Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Jan 2026 for Cabaletta Bio, Inc., €8,511.
Filing timeline
BuySaleCatherine Bollard
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+367.4%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +7.8%Entry US$2.94 · Close at T+90 US$3.17
- +915.8%Entry US$1.30 · Close at T+365 US$13.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Catherine Bollard: trading record in brief
Catherine Bollard appears in our data through filings on Cabaletta Bio, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 18 October 2022 to 21 January 2026.
No open-market sale appears; the market trades are 2 purchases worth €9,519. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.
The latest filing, published on 21 January 2026, reports an open-market purchase of €8,511 in Cabaletta Bio, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Catherine Bollard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,405 shares@ US$2.266189.4% of flowCommon StockSEC:0001193125-26-018319:0
Canonical exit: 21 Apr 2026 (T+90)
1,000 shares@ US$0.993510.6% of flowCommon StockSEC:0000899243-22-033783:0
Canonical exit: 16 Jan 2023 (T+90)
2 of 2 declarations
